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ORIGINAL ARTICLE
The aim of this study was to assess the success and 
complication rates for PTA in the treatment of fistula mal-
function because of inflow stenosis regardless of the de-
gree of maturation. 
Materials and Methods
An inflow stenosis was defined as stenosis within the 
following areas: the feeding artery, the artery-vein anasto-
mosis comprising 1 cm of vessel length on both sides of 
the anastomosis and the juxta-anastomotic region (the first 
2 cm downstream from the anastomosis) (12) and drain-
age vein which involved the puncture area. All fistulas 
with stenoses outside this area were excluded. 
The referral criteria analyzed in dysfunctional fistula 
were one of the following: 1) insufficient development 
after one month upon creation, 2) difficulties in cannula-
tion, 3) inability to deliver 300 mL/min dialysis flow, 4) 
prolonged hemostasis and 5) inadequate Kt/V. Vascular 
stenosis was defined as significant if it caused a ≥50% re-
duction in luminal diameter judged by comparison with 
the adjacent vessel or graft. Stenoses were considered sim-
introduction
Regardless of the development in nephrologic care, 
chronic kidney disease patients still have a high morbidity 
and mortality, mainly because of vascular related dysfunc-
tion, as demonstrated by the DOPPS study (1). Pisoni et 
al have revealed that the increased prevalence of central 
venous catheters and grafts was associated with consid-
erably higher mortality and hospitalization risks (2). The 
European Best Practice Guidelines (EBPG) recommend 
the placement of arterio-venous fistulas over grafts (3), 
nonetheless, 28% to 53% of fistulas will not mature upon 
creation to support dialysis therapy and 10% to 80% will 
suffer from dysfunction in the long-term (4-6). 
Percutaneous transluminal angioplasty (PTA) has prov-
en to be valuable for management of dysfunctional fistula 
(7-11), and in 1997, American KDOQI guidelines acknowl-
edged for the first time the role of interventional angioplasty 
for treatment of vascular access dysfunction (6). In the last 
few years, several studies have demonstrated that this tech-
nique is efficient and safe, enabling preservation of veins, 
avoiding the need for a new access and eventually the need 
for catheter while the new access matures (7-10). 
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Purpose: Autogenous fistulas are the preferential vascular access for hemodialysis. The aim of this retrospective study was to 
determine the efficacy of angioplasty for dysfunctional fistulas because of inflow dysfunction. 
Methods: We reviewed all the angiographic procedures performed on our institution between April 2007 and April 2009. 
Procedures performed in dysfunctional fistulas because of inflow stenoses were analyzed. Fistulas with stenoses out of these 
areas were excluded. The following data were collected: patient age and sex, fistula age at the time of intervention, location 
of fistula, number and location of stenosis, angiography referral criteria, clinical findings (presence or absence of thrills, 
bruits and pulsatility) and date of reintervention or failure. 
Results: During the study period 215 fistulas were submitted to angiography of which, seventy-one presented inflow ste-
nosis (33%). Mean follow-up was 21.72±9.26 months, and average age was 7.03 months. Two groups were considered: 31 
fistulas comprising ≤6 months old, and 40 fistulas >6 months old. Primary patency rates±SE for older fistulas at 6, 12, 18 
and 24 months, respectively, was 91.3%± 0.04%, 80.7%± 0.07%, 53.8% ±0.10% and 34.2±0.1%. versus 91.7±0.08%, 
57.1±0.14%, 23±0.14%, 11.4%± 0.1% for younger fistulas (P=0.04). Fistulas ≤6 months old and multiple stenosis were as-
sociated with a poorer primary patency rate (P=0.005).
Conclusions: Inflow stenosis is frequently associated with fistula dysfunction. In this study we only analyzed AVF with inflow 
stenosis and we have shown that angioplasty can have great patency results, particularly for single lesions in matured fistulas. 
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considered positive if the fistula provided adequate dialy-
sis for at least one session, at 300 mL/min flow rate with-
out recirculation. This was achieved by consultation of the 
dialysis charts or questioning the medical team. Anatomic 
success was defined if the stenosis disappeared. 
Follow-up 
All the information for each patient was obtained from 
medical records maintained by the dialysis unit. Complica-
tions were categorized as major or minor as published guide-
lines of the SIR (14). Complications associated with impaired 
clinical consequences, death, need for an additional inter-
vention or inpatient hospitalization were considered major. 
Statistical analysis
Primary and secondary patency rates were estimated 
using the Kaplan–Meier life-table method, and tested us-
ing the log rank test. All fistulas surviving up to the end of 
the study were considered and data censored if the pa-
tients were lost to follow-up, dead with a patent fistula, 
transferred to another dialysis center or submitted to kid-
ney transplant and, subsequently, without any information 
available on the status of the fistula. 
The Student t test or Wilcoxon rank sum test were used 
for univariate analysis of continuous variables; categoric 
variables were assessed using the χ2 or Fisher exact test, as 
appropriate. A P  value of 0.05 was used to determine statisti-
cal significance. Cox proportional hazards regression model 
was performed for primary patency using the following fac-
tors: patient age and sex, type of fistula, side of fistula, age of 
the fistula before first intervention (less than or equal to six 
months or more than six months), number of venous stenosis 
dilated (n = 1 vs. n > 1) and the location of the stenosis (with 
arterial versus without arterial involvement). 
results
From April 2007 to April 2009, 215 patients with dys-
functional fistulas were analyzed. One hundred and six-
teen patients presented vascular stenoses in the outflow 
area. In 28 patients, dysfunctional fistulas were because 
of the presence of several collateral vessels. Both these 
groups were excluded. Seventy-one patients presented an 
inflow stenosis (33%) (Fig. 1). 
Table I shows demographic data for this group of pa-
tients. Patients were followed for 21.72±9.26 months, 
median 19.98 months (minimum seven months, maxi-
mum 31 months), mean age 64 years old, 57.7% men. 
At the time of intervention, fistula age had a median of 
7.03 months. Thirty-one fistulas (43.7%) were less than six 
months, with a mean age of 3.77±1.11, median 3.58 (1.9 
to 5.6 months) and 40 fistulas (56.3%) were older than 
ple, if unique, or multiple, if more than one. Clinical as-
sessment of the fistula included the detection of abnormal 
findings of weak or absence of thrill, pulsatility, changes 
in bruits, and direct palpation of stenosis. Clinical vari-
ables included patient age and sex, fistula age at the time 
of procedure, location of fistula, number and location of 
stenosis, type and number of interventions performed in 
each fistula, date of failure or reintervention. 
All interventions were performed in patients on regular 
hemodialysis sessions and as outpatient procedures by two ne-
phrologists trained in vascular intervention for at least six years. 
Infection was the only absolute contraindication for the pro-
cedure. Surgical revision on the previous 10 days and iodine 
allergic reaction were considered relative contraindication. 
Angiography was performed by a venous retrograde 
approach, using direct puncture of the vascular access us-
ing an 18G needle and placement of a 7F or 8F dilator 
introducer sheath since those were the only ones avail-
able in our center. Local analgesia was provided by lido-
caine administration at the puncture site and at the site of 
stenosis. If a stenosis was present, a wire was passed and 
the appropriately high-pressure balloon catheter was then 
advanced to the stenotic area. Stenoses were treated us-
ing a standard angioplasty technique with high pressure 
balloons (‘Blue-Max’, Medi-Tech, Natick, Ma, or ‘Centu-
rion’, Bard, Covington, GA, USA). The balloon was then 
inflated up to the maximal recommended pressure and/or 
to abolish the waist of the stenosis on the balloon for up 
to two minutes. The size of the balloons was dependent 
of the size of the adjacent vessels. No anticoagulant or 
other intravenous medication was used. The final result 
was assessed clinically and angiographically, respectively; 
reappearance of a countinuous thrill over the access and 
stenosis disappearance. Blood flow was also assessed at 
the end of the procedure, analyzing the velocity of blood 
upon administration of intravenous contrast. In cases of 
dilation-induced rupture of the vein, the dilation balloon 
was first reinflated locally at low pressure (6–8 atm) for 
periods of 10 minutes, up to three times. If the rupture 
persisted, stent placement would have been considered.  
Definitions and end points
Primary and secondary patencies after intervention 
were defined according to the Society of Interventional 
Radiology (SIR) (13-14). Primary patency was defined as 
patency during the interval between primary intervention 
and fistula thrombosis or repeated radiologic intervention. 
Secondary patency was defined as patency during the in-
terval between primary intervention and the time when 
the fistula had surgical intervention or is abandoned. Cu-
mulative patency was considered as the total time the ac-
cess remains patent regardless of interventions. 
After angiographic intervention, two definitions were 
used, clinical and anatomic success. Clinical success was 
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six months, with a mean age of 21.62 months, median 
11.50 (6.2 to 161 months). Most fistulas were brachioce-
phalic (46.5%) and 64.7% were located on the left side. 
In the group of fistulae ≤6 months, 54.8% were radioce-
phalic and 35.5% were brachiocephalic and in fistulae 
>6 months, 39% were radiocephalic and 52.8% brachio-
cephalic. The most frequent criteria of fistula dysfunction 
was insufficient development (22.5%) and inability to 
deliver 300 mL/min (42.3%) of blood flow. All the fistu-
las were very pulsatile and a weak or absent thrill was 
noted. In 15/71 cases, no procedure was performed, and 
the patients were referred to surgery (Fig. 1). In eight of 
these fistulas, two radiocephalic and six brachiocephalic, 
there was complete occlusion of the venous outflow ap-
proximately 4-6 cms after anastomosis. These fistulas had 
a mean age of eight months, median four months; two 
of them were 17 and 25 months old. A wire and a cath-
eter were tried through the stenosis, but unsuccessfully. In 
six fistulas, the stenosis was critical, being located at the 
anastomosis (>90%) and associated with a reduction in 
the caliber of the radial artery over its entire extension up 
to the elbow. The last patient presented a stenotic lesion 
in the venous outflow associated with an important aneu-
rism lesion in the juxta-anastomotic area.  
TAblE I - DEMOGRAPHIC DATA
Variable Patients (n=71)
Age of patient (y)                     64±14
Sex                
       Male















Age of Fistula at first intervention (mean) 14, median 7.03
Number of Fistula 













Fig 1 - Scheme representing all the fistulas (AVF) submitted to angiog-
raphy (AS=arterial stenosis; VD= vein drainage, PTA=percutaneous an-
gioplasty).
Angioplasty was performed in 56 cases. Thirty-eight 
fistula out of 41, older than six months, underwent angio-
graphic procedure compared to only 18/31 fistula less than 
six months old (P=0.00025, Fisher’s exact test ). 
Single stenoses were the predominant lesion in 59.2% 
of cases (Tab. II). These lesions were predominantly located 
at the puncture and juxta-anastomosis areas. Multiple lesions 
also predominantly affected the juxta-anastomosis and punc-
ture areas. In 10 cases (14.1%), the artery was affected, and 
angioplasty was successful in 6/10 (60%) cases. One of these 
patients had multiple stenotic lesions along the radial artery 
up to the elbow and successfully underwent PTA. 
Fistulas younger than six months presented predominant-
ly single stenosis (74.2%) and fistulas older than six months 
old mainly showed multiple lesions in 52.5% (P=0.08, Fish-
er’s exact test). 
Angioplasty had an anatomic success of 100%, achieved 
in 56/56 patients and a clinical success in 98.2% attained in 
55/56 patients. All the successfully treated fistulas recovered a 
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strong thrill and the pulsatility disappeared. Intention to treat 
analysis revealed a clinical success in 77.5%. 
During the follow-up period 11 patients died with a 
functioning access and one patient underwent renal trans-
plant, still having a functioning fistula at the end of the study. 
Nine patients suffered fistula thrombosis, and seven patients 
required a total of 10 repeated successful endovascular pro-
cedures. The total fistula event rate was 0.18 events/access-
year. The fistula loss rate was 0.08/access–year. 
Figure 2 shows the Kaplan-Meier curve of estimated 
primary patency after first angioplasty in all fistulas. Es-
timated median survival was 19.3 months and mean pri-
mary patency rate±standard error(SE)  at 6, 12, 18 and 24 
months was 93.9%± 3.44%, 77.2± 6.4%, 52.4% ± 8.5% 
and 28±8.1%, respectively. 
Table III shows the survival rates for radiocephalic and 
brachiocephalic fistulas. No statistically significant differ-
ence was found between the survival rates (P=0.6, logrank 
test). No analysis was performed for transposed basilica, 
because of a reduced number of this type of fistula. 
Kaplan-Meier curve of estimated primary patency after 
first angioplasty for fistulas older than six months revealed 
estimated median survival of 20 months and a primary 
patency rate±SE at 6, 12, 18 and 24 months of 91.3%± 
0.04%, 80.7%± 0.07%, 53.8% ±0.10% and 34.2±0.1%, 
respectively. For fistula younger than six months, median 
survival was 17.67 months and primary patency rate±SE 
at 6 months, 12 months, 18 months and 24 months was 
91.7±0.08%, 57.1±0.14%, 23±0.14%, 11.4%± 0.1%, re-
spectively. Logrank test showed a statistically significant 
difference between the survival rates, P=0.04 (Fig. 3). 
Cumulative mean patency from the time of fistula es-
tablishment to fistula loss, end of the study or reinterven-
TAblE II - TyPE AND LOCATION OF STENOSIS 
Stenosis Fistulas (n=71)
Type of stenosis
Complete occlusion of venous outflow 
Single Stenosis
Multiple Stenosis
9* (Seven fistulas <6 months 










FAV < 6 months
Complete occlusion DV not PTA
Complete occlusion DV by PTA
Single Stenosis treated by PTA
        Artery
        Anastomosis
        JAV
        DV
Stenosis not treated by PTA
        Single stenosis 
        Multiple stenosis**
 Multiple Stenosis treated by PTA
        Artery+JAV
        Artery + DV
        Anastomosis +JAV
        JAV+DV
        Artery+AV+JAV


















FAV > 6 months
Complete occlusion DV not PTA
Single Stenosis treated by PTA
               Artery
     AV 
     JAV
     DV
Multiple Stenosis treated by PTA
     Artery+AV
     Artery+JAV
     AV+JAV
     AV+DV
     JAV+DV















Anatomic success of PTA 100% (56/56)
Clinical success of PTA 98.2% (55/56)



























AV, anastomosis; DV, drainage vein; JAV, juxta-anastomosis; PTA, percutaneous 
angioplasty. 
*One of these fistulas was successfully submitted to angioplasty, but suffered early 
thrombosis; **All associated with a very narrowed artery over its entire extension, 
with no visible stenosis; one patient also had an aneurysm) 
Fig. 2 - Kaplan Meier curve of estimated primary patency after first an-
gioplasty in all fistulas. Crosses indicated censored observations 95% 
confidence intervals are represented by the less dark line. 
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tion was 32.79 months, median 25.60 months, ranging 
from 5.3 to 186.26. Cumulative mean patency for fistula 
older than six months was 42.5 months, median 31 rang-
ing from eight months to 186 months, and fistulas less 
than six months old had a cumulative mean patency of 17 
months, median 16.2 months, ranging from 5.3 months to 
29.43 months, P<0.0005.
Secondary patencies were determined on seven pa-
tients who underwent repeated angioplasty. Mean sec-
ondary patency was 11 months, median nine months. 
The Kaplan-Meier curve of estimated secondary patency 
showed an estimated survival of 19 months, with a sec-
ondary patency rate at nine months of 75±21.7%. 
Complications were five cases of acute rupture, which 
occurred during dilation (8.9%), three treated by pro-
longed balloon insufflations. In two fistulas, a stent was 
required, and one of these fistulas was still patent at the 
end of the study. No other complications (fistula infec-
tion, development of aneurism, patient death or need for 
hospitalization) were observed. The mean procedure time 
was 35 minutes with median 41 minutes (28 to 218 min). 
Cox proportional hazard regression was performed for 
Fig. 3 - Kaplan Meier curve of estimated primary patency after first angioplasty in fistula older than 6 months (A) and < 6 months  (B). Crosses indicated 
censored observations and 95% confidence intervals are represented by the less dark line.
a b




6 12 18 24
Radio-
cephalic
17.67 90.7±6.3% 65.5±10.6% 41.7±11.7% 22±9.6%
Brachio-
cephalic
24.2 94.4±5% 81.5±9.8% 62.9±14% 41.9±15.3%
primary patency. The statistically significant factors were num-
ber of stenosis (P=0.005) and age of fistula (older or younger 
than six months at the time of intervention) (P=0.005). 
discussion
Arterio-venous fistula (AVF) has the greatest longevity, 
lower complication rate (2) and the lowest upkeep value 
of all types of access (15). PTA is considered the preferred 
method of treatment for dysfunctional AVF since it appears 
to be as efficient as the surgical approach in terms of access 
survival and cost, even if primary patency for pre-emptive 
surgical repair is better (89%±6, at 12 months) (16-19) . 
Surgery resolves AVF dysfunction by creating a new, more 
proximal anastomosis with subsequent venous capital loss, 
or by using graft interposition. It is noteworthy to point out 
that both surgical repair or endovascular treatment have 
better results if performed in nonthrombosed vessels (9).
Monitoring vascular blood flow plays an important 
role for early detection of stenoses and, consequently, 
reducing the rate of thrombosis (20, 21). If this surveil-
lance is not performed correctly, angioplasty might lose 
its advantage over the surgical approach (22-24). We did 
not perform any access Qa monitoring at the time, before 
or after angioplasty, and the referral method for this study 
was based solely on clinical criteria; even so we achieved 
reasonable results, emphasizing the importance of clinical 
monitoring of hemodialysis accesses. Other surveillance 
techniques are associated with earlier detection of ste-
notic lesions, particularly when dysfunction comes from 
inflow lesions; however physical examination remains an 
invaluable monitoring method (25).
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sites along the drainage vein (9,19). In fact, percutaneous 
angioplasty has demonstrated disappointing data on the 
management of cephalic arch stenosis, probably because 
of multiple factors including the resistant nature of the ste-
nosis, the development of early restenosis, as well as poor 
patency and high vein rupture rates (27). 
The estimated secondary patency is rather good and 
comparable to others (8, 19). It is not possible to draw 
any definitive conclusions as statistical analysis was only 
performed in seven cases. 
Our data also revealed that PTA is successful for old 
and young fistula, but the results are significantly better 
for older fistulae and for fistulae with only one stenosis. In 
some studies the age of the access at the time of interven-
tion is not obvious, but Manninen et al clearly demon-
strated that endovascular treatment is more effective for 
matured than for nonmatured fistula (32). Several publica-
tions have emphasized the value of endovascular tech-
niques in the salvage of nonmaturing fistulas (7, 33, 34).
Vascular stenosis is because of neointimal hyperplasia 
and the events leading to the development of this lesion 
appear to begin early on with surgical manipulation at the 
time of access construction, hemodynamic stress at the 
anastomotic site, venous puncture and uremia (28,29). In 
this study 40.8% fistulae had multiple stenoses particu-
larly located at the anastomotic and puncture area, similar 
to other data (7-9). Of note, our results showed a higher 
incidence of multiple lesions, although not statistically 
significant, on fistulae older than six months, particularly 
involving the puncture area and this finding is certainly 
related to venous punction (29). 
Cox analysis showed that the age of fistula at the time 
of intervention and number of stenoses predicted patency. 
Patient age, side and location of the fistula and patient sex 
did not affect the results. We have no available data on 
diabetes. 
We have used retrograde puncture as others (8,35) 
although arterial puncture may provide a better charac-
terization of the vascular tree, as the vascular stenosis 
may be located far from fistula anastomosis, such as the 
aortic arch (12). We were able to dilate arterial stenosis 
presented in 14.1% (10/16 fistula) of fistulas. In six cases, 
we decided not to perform any angioplasty as the arteries 
presented a reduced caliber over their entire extension up 
to the elbow without visible stenosis and consequently, 
we assumed that the artery was anatomically inadequate 
to support the development of fistula. Recently, Turmel-
Rodrigues et al argued that the arteries that did not enlarge 
after construction of an arteriovenous anastomosis, should 
be considered as an overall stenosed artery that could be 
mechanically dilated safely and effectively by an angio-
plasty balloon (36).
This study has the limitations inherent of being a retro-
spective and nonrandomized study. However, all the pro-
cedures were performed by two experienced physicians 
 EBPG recommend that only a functionally significant 
stenosis, defined as a decrease of more than 50% of nor-
mal vessel diameter, together with a reduction in access 
flow or in measured dialysis dose, or stenosis associated 
with difficulties in cannulation, painful arm, edema, hand 
ischemia or prolonged bleeding, should be assessed (3). 
In this study, all the stenoses presented a decrease of more 
than 75% of normal vessel diameter and were associated 
with clinical signs of dysfunction (e.g. weak or absent 
thrill).
Our study was performed on dysfunctional fistula and 
in whom angiography demonstrated an inflow stenosis. 
Venous problems have been regarded as the principal cul-
prits for access dysfunction for a long time, with much 
less importance given to inflow problems which had an 
incidence of 0% to 4% (12). Although, in the last few 
years, inflow stenoses have been shown to be present in 
approximately 25% to 50% of the dysfunctional access 
(12-26). Both radiocephalic and brachiocephalic fistulas 
commonly fail because of lesions located within the peri-
anastomotic region; however, more proximal stenoses 
can also occur in both cases, especially in the case of 
brachiocephalic fistulas (cephalic arch stenosis) (27). The 
histology of this venous stenosis is characterized by an ag-
gressive neointimal hyperplasia in both AV grafts and fis-
tulas whose mechanism is not completely understood but 
characterized by the presence of myofibroblasts, smooth 
muscle cells and microvessels in the neointima (28,29). 
Our data shows the role of percutaneous angioplasty in 
the treatment of inflow stenosis causing maturation failure 
or dysfunction of matured fistula. The estimated survival 
and patency rate as determined by Kaplan-Meier analysis 
are comparable to the data of others (8,9,16,30) as shown 
by an estimated survival of 93.9%± 3.44%, 77.2± 6.4%, 
52.4% ± 8.5% respectively for 6, 12 and 18 months. Inter-
estingly, we found no difference between primary patency 
for radiocephalic fistulas and brachiocephalic fistulas, as 
opposed to others who have shown higher primary paten-
cy for radiocephalic fistulas (8,9). In fact, in this study, pri-
mary patency rates for brachiocephalic fistulas are slightly 
superior to those found in the literature, that is 94.4%, 
81.5%, 62.9%, respectively for 6, 12 and 18 months ver-
sus 75%, 51% and 41% for 6, 12 and 18 months (19), 
51% and 39% (8) and 84%, 35% (9) for 6 and 12 months, 
respectively. Of note, other studies have included dys-
functional fistulas because of stenosis located at several 
sites, namely cephalic vein in the venous outflow, cephal-
ic arch, subclavian or other central veins which acted as 
confounding factors, and most certainly account for this 
difference (8,9). Rajan et al demonstrated that angioplasty 
of cephalic arch stenosis, predominantly, associated with 
brachiocephalic fistula, showed a primary patency rates 
at 3, 6 and 12 months of 76%, 42% and 23%, respec-
tively (31), in contrast to other studies that have included 
brachiocephalic fistula with stenosis located at different 
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(two authors) and, therefore, variation in methods of treat-
ment are avoided. 
In conclusion, PTA appears to be an effective treat-
ment for dysfunctional fistulas because of inflow stenosis 
particularly for matured fistulas, and able to treat the mul-
tiple lesions frequently presented. Multiple stenosis and 
younger age of fistulas were the factors that reduced pa-
tency rate after PTA.
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